Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.
Comprising a fresh issue and offer for sale by promoter shareholders. The IPO saw an exceptional overall subscription of 93.71 times, with QIB demand at 213.08 times.